Skip to main content
SpringerLink
Log in

Medical Applications

  • Chapter
  • First Online:
An Intraoperative Beta−Probe for Cancer Surgery

Part of the book series: Springer Theses ((Springer Theses))

  • 238 Accesses

Abstract

In Chap. 1 a comprehensive summary of the actual status of tumor surgery was outlined. In Sect. 1.1 the outmost importance of full tumor resection was highlighted, and a review of all the available techniques to this purpose was presented.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. J.H. Lee, Meningiomas: Diagnosis, Treatment, and Outcome (Springer Science and Business Media, Heidelberg, 2011)

    Google Scholar 

  2. G. Wrobel, P. Roerig, F. Kokocinski, K. Neben, M. Hahn, G. Reifenberger, P. Lichter, Microarray-based gene expression profiling of benign, atypical and anaplastic meningiomas identifies novel genes associated with meningioma progression. Int. J. Cancer 114(2), 249–256 (2005)

    Article  Google Scholar 

  3. V.K.K.V.K.P. Sakellariou, Surgical outcome of treating grades ii and iii meningiomas: a report of 32 cases. Neurosci. J. 2013, 249–256 (2013)

    Google Scholar 

  4. L.S. Chin, B.E. Lazio, T. Biggins, P. Amin, Acute complications following gamma knife radiosurgery are rare. Surg. Neurol. 53(5), 498–502 (2000)

    Article  Google Scholar 

  5. S.L. Stafford, B.E. Pollock, R.L. Foote, M.J. Link, D.A. Gorman, P.J. Schomberg, J.A. Leavitt, Meningioma radiosurgery: tumor control, outcomes, and complications among 190 consecutive patients. Neurosurgery 49(5), 1029 (2001)

    Google Scholar 

  6. J. Reubi, R. Maurer, J.G. Klijn, S.Z. Stefanko, J.A. Foekens, G. Blaauw, M.A. Blankenstein, S.W. Lamberts, High incidence of somatostatin receptors in human meningiomas: biochemical characterization. J. Clin. Endocrinol. Metab. 63(2), 433–438 (1986). PMID: 3013920

    Article  Google Scholar 

  7. F. Collamati, A. Pepe, F. Bellini, V. Bocci, M. Cre, E. D. Lucia, P. M. Frallicciardi, C. M. Grana, M. Marafini, A. Russomando, A. Sarti, A. Sciubba, M. Senzacqua, E.S. Camillocci, C. Voena, R. Faccini, D. Fisica, S. Universita, I. Sezione, L. Nazionali, Towards a radio-guided surgery with beta- decays: uptake of a somatostatin analogue (dotatoc) in meningioma and high grade glioma, 0, 0, 1–17 (2014)

    Google Scholar 

  8. A. Loening, Amide: a medical image data analysis tool, v 1.0.4 (2000–2012)

    Google Scholar 

  9. K. Hemminki, X. Li, Incidence trends and risk factors of carcinoid tumors. Cancer 92(8), 2204–2210 (2001)

    Article  Google Scholar 

  10. I.M. Modlin, K.D. Lye, M. Kidd, A 5-decade analysis of 13,715 carcinoid tumors. Cancer 97(4), 934–959 (2003)

    Article  Google Scholar 

  11. J.C. Yao, M. Hassan, A. Phan, C. Dagohoy, C. Leary, J.E. Mares, E.K. Abdalla, J.B. Fleming, J.-N. Vauthey, A. Rashid, D.B. Evans, One hundred years after “carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J. Clin. Oncol. 26(18), 3063–3072 (2008), http://jco.ascopubs.org/content/26/18/3063.full.pdf+html

    Google Scholar 

  12. B. Eriksson, B. Annibale, E. Bajetta, E. Mitry, M. Pavel, M. Platania, R. Salazar, U. Ploeckinger, Enets consensus guidelines for the standards of care in neuroendocrine tumors : chemotherapy in patients with neuroendocrine tumors. Neuroendocrinology 90(2), 214–219 (2009)

    Article  Google Scholar 

  13. S.M. Bison, M.W. Konijnenberg, M. Melis, S.E. Pool, M.R. Bernsen, J.J.M. Teunissen, D.J. Kwekkeboom, M. de Jong, Peptide receptor radionuclide therapy using radiolabeled somatostatin analogs: focus on future developments. Clin. Transl. Imaging: Rev. Nucl. Med. Mol. Imaging 2, 55–66 (2014). Jan

    Article  Google Scholar 

  14. F. Guerriero, M.E. Ferrari, F. Botta, F. Fioroni, E. Grassi, A. Versari, A. Sarnelli, M. Pacilio, E. Amato, L. Strigari, L. Bodei, G. Paganelli, M. Iori, G. Pedroli, M. Cremonesi, Kidney dosimetry in 177Lu and 90Y peptide receptor radionuclide therapy: influence of image timing, time-activity integration method, and risk factors. BioMed Res. Int. 2013, 935351 (2013)

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. National Laboratories of Frascati, National Institute of Nuclear Physics, Frascati, Italy

    Francesco Collamati

Authors
  1. Francesco Collamati
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Francesco Collamati .

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Collamati, F. (2016). Medical Applications. In: An Intraoperative Beta−Probe for Cancer Surgery. Springer Theses. Springer, Cham. https://doi.org/10.1007/978-3-319-33699-2_4

Download citation

Publish with us

Policies and ethics

Search

Navigation